Court of Arbitration for Sport Decision - Essendon Players

12 January 2016

The Australian Sports Anti-Doping Authority (ASADA) today acknowledged the decision of the Court of Arbitration for Sport (CAS) to impose two year bans on 34 current and former Essendon Football Club players for the use of the prohibited substance Thymosin Beta 4.

The CAS result is final and overturns the decision of the AFL Anti-Doping Tribunal announced in March 2015. It comes in response to the World Anti-Doping Agency’s (WADA) appeal of that Tribunal decision, which ASADA assisted in and strongly supported.

Despite the absence of positive test results, WADA was able to use evidence gathered by ASADA to prove that the players had been injected with the prohibited substance as part of a team program designed to give Essendon an unfair advantage in the 2012 season.

The evidence included text messages outlining a plan to source Thymosin Beta 4 for the purpose of doping the Essendon team, testimonies from players and officials, and a scientific analysis of substances sourced for the team.

It is the same evidence ASADA presented to the AFL Tribunal, however the different outcome represents the proper application of the burden of proof – comfortable satisfaction – as intended by the World Anti-Doping Code.

ASADA CEO Ben McDevitt said: “This unfortunate episode has chronicled the most devastating self-inflicted injury by a sporting club in Australian history.”

On the sanctions, he said: “There were very little grounds for the players to claim they were at no significant fault.”

“The players had received anti-doping education through the AFL and ASADA, and were well aware that they are personally responsible for all substances that entered their body.”

“Unfortunately, despite their education, they agreed to be injected with a number of substances they had little knowledge of, made no enquiries about the substance and kept the injections from their team doctor and ASADA.”

“Of 30 ASADA testing missions during the period in question, none of the 18 players tested declared the injections, despite being asked each time whether they had taken any supplements.”

“At best, the players did not ask the questions, or the people, they should have. At worst, they were complicit in a culture of secrecy and concealment.”

“The CAS result brings this matter to a close and ASADA looks forward to continuing to work with all sporting codes to promote a clean and fair sporting environment.”

The two-year ban imposed by the CAS has been backdated on a case by case basis, with respect to time already served by the players who accepted provisional suspensions in 2013, and delays to the case outside of the players’ control.

The table below shows the sanctions applied to each player. Until then, each player is ineligible to participate, as an athlete or support person, in any sports that have adopted a World Anti-Doping Agency compliant anti-doping policy.

 

Player

Expiry of ineligibility

Thomas Bellchambers

13 November 2016

Alex Browne

13 November 2016

Jake Carlisle

13 November 2016

Travis Colyer

13 November 2016

Stewart Crameri

13 November 2016

Alwyn Davey

15 February 2017

Luke Davis

13 November 2016

Cory Dell’Olio

14 November 2016

Ricky Dyson

13 November 2016

Dustin Fletcher

21 November 2016

Scott Gumbleton

13 November 2016

Kyle Hardingham

13 November 2016

Dyson Heppell

13 November 2016

Michael Hibberd

13 November 2016

David Hille

13 November 2016

Heath Hocking

13 November 2016

Cale Hooker

13 November 2016

Ben Howlett

13 November 2016

Michael Hurley

13 November 2016

Leroy Jetta

15 February 2017

Brendan Lee

13 November 2016

Sam Lonergan

13 November 2016

Nathan Lovett-Murray

15 December 2016

Mark McVeigh

13 November 2016

Jake Melksham

13 November 2016

Angus Monfries

13 November 2016

David Myers

13 November 2016

Tayte Pears

13 November 2016

Brent Prismall

13 November 2016

Patrick Ryder

13 November 2016

Henry Slattery

13 November 2016

Brett Stanton

13 November 2016

Ariel Steinberg

13 November 2016

Jobe Watson

21 November 2016

 

Tags: